Effect of Nigella sativa Intake on Oxidative Stress and Inflammation in Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- 2024-05
- Current pharmaceutical biotechnology 25(7)
- Hossein Hosseini
- Farideh Ghavidel
- Mahdieh Aliyari
- Seyed Isaac Hashemy
- Tannaz Jamialahmadi
- Amirhossein Sahebkar
- PubMed: 37859312
- DOI: 10.2174/0113892010266109230928000134
Study Design
- Type
- Meta-Analysis
- Sample size
- n = 1,033
- Population
- 1033 participants diagnosed with metabolic syndrome and its associated conditions
- Methods
- Meta-analysis of 16 RCTs; search conducted on Web of Science, Scopus, PubMed, and EMBASE until August 2023
Background
Several studies have shown that the intake of N. sativa has a beneficial effect on metabolic syndrome and related disorders. In this meta-analysis, our primary objective was to assess the impact of Nigella sativa consumption on inflammation and oxidative stress biomarkers among individuals diagnosed with metabolic syndrome and its associated conditions.Methods
Our search was conducted on prominent online databases such as Web of Science, Scopus, PubMed, and EMBASE, utilizing relevant keywords until August 2023.Results
This meta-analysis was performed on 16 RCTs comprising 1033 participants. Our results showed that intake of Nigella sativa significantly decreased CRP (SMD: -0.60; (95% CI: from -0.96 to -0.23); P = 0.00), TNF-α (SMD: -0.53; (95% CI: from -0.74 to -0.53); P = 0.00); IL-6 (SMD: -0.54 ; (95% CI: from -1.01 to -0.07); P = 0.02), and MDA: (SMD: -1.28; (95% CI: from -2.11 to -0.46); P = 0.00) levels. In addition, SOD: (SMD: 1.35; (95% CI, from 0.77 to 1.93); P = 0.00) and TAC (SMD: 2.82; (95% CI, from 0.55 to 5.084); P = 0.01) levels significantly increased in the intervention group compared to the placebo group.Conclusion
Our results showed that THE consumption of N. sativa could be associated with improved oxidative stress and inflammation in patients with metabolic syndrome and related disorders.Research Insights
SOD: (SMD: 1.35; (95% CI, from 0.77 to 1.93); P = 0.00) levels significantly increased
- Effect
- Beneficial
- Effect size
- Large
TAC (SMD: 2.82; (95% CI, from 0.55 to 5.084); P = 0.01) levels significantly increased
- Effect
- Beneficial
- Effect size
- Large
intake of Nigella sativa significantly decreased CRP (SMD: -0.60; (95% CI: from -0.96 to -0.23); P = 0.00)
- Effect
- Beneficial
- Effect size
- Moderate
intake of Nigella sativa significantly decreased IL-6 (SMD: -0.54 ; (95% CI: from -1.01 to -0.07); P = 0.02)
- Effect
- Beneficial
- Effect size
- Moderate
intake of Nigella sativa significantly decreased MDA: (SMD: -1.28; (95% CI: from -2.11 to -0.46); P = 0.00)
- Effect
- Beneficial
- Effect size
- Large
intake of Nigella sativa significantly decreased TNF-α (SMD: -0.53; (95% CI: from -0.74 to -0.53); P = 0.00)
- Effect
- Beneficial
- Effect size
- Moderate